Type 1 Diabetes Clinical Trials in Pittsburgh, Pennsylvania

3 studies are recruiting for type 1 diabetes in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

    This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to <21 with recent-onset stage 3 T1D.

    Stage
    Phase 1
    Ages
    9 to 20
    Site
    University of Pittsburgh, Pittsburgh, Pennsylvania
    Locations
    10 in total
    Run by
    City of Hope Medical Center
  2. SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

    This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

    Stage
    Phase 2
    Ages
    5 to 40
    Site
    UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    Locations
    70 in total
    Run by
    SAb Biotherapeutics, Inc.
  3. An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

    This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh, Pennsylvania
    Locations
    7 in total
    Run by
    Vertex Pharmaceuticals Incorporated

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.